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Abstract The chemotherapy and photon radiotherapy are
the most often applied methods in treatment of the cancer
diseases because of their effectiveness and high cure rates.
Apart from eligible destruction of the tumour, one of the
side effects of these treatment methods is possible modifi-
cation of main and trace element concentration in different
human tissues and fluids. In this paper, the copper (Cu)
level in human serum was determined by total reflection X-
ray fluorescence method in 142 chemotherapy patients and
in 44 healthy persons being a control group. The Cu con-
centration in the chemotherapy group was found to be on
the level 1.78 ± 0.909 mg/L, while in the control group, it
was 1.08 ± 0.551 mg/L. Performed measurements allowed
for calculation of the parameters of copper concentration
distribution (mean value, standard deviation, median) for
both analysed groups. The theoretical nature of the concen-
tration distribution was tested and found as a log-normal
distribution (control group) and a log-stable distribution
(chemotherapy group). The copper concentration distribu-
tions for both studied group were statistically compared
using Kolmogorov-Smirnov test, and the conclusion was
that the distributions are statistically different. Serum Cu
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levels were significantly higher in the chemotherapy group
than in the control group. Taking into account the results
for the control group, the copper concentration reference
quantile ranges in human serum were obtained. The val-
ues of the mean, median and other quantiles determined in
this case can be applied in two-group comparison studies.
The obtained results can be used as a diagnostic tool for
chemotherapy patients.
Keywords Copper in human serum · TXRF method ·
Chemotherapy · Log-normal distribution · Log-stable
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Introduction
The contents of trace elements in biomedical samples are
of great interest for biology, medicine and environmental
sciences. In our laboratory, different types of biomedical
samples, e.g. urine, serum, blood, breast, foetal membranes
and placenta samples have been studied in recent years [1].
Studies on the concentration of trace elements in biomedical
samples have been performed by application of one of the
most known techniques, namely the total reflection X-ray
fluorescence (TXRF) method [2]. This method allows fast
and accurate, simultaneous analysis of all elements heavier
than aluminium (for measurements in air) and is routinely
used in medical applications, in particular, to study on the
content of heavy metals in different samples of medical
interest [1, 3–5]. Our investigations had different motiva-
tions but were mainly focused on the development of new
possibilities of cancer diagnosis and therapy monitoring as
well as investigation of people’s health related to different
aspects of environmental pollution. Performed measure-
ments yielded rather systematic data on the concentration
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distributions of trace elements in biomedical samples, thus
allowing a formulation of general conclusions related to the
nature of observed concentration distributions as well as
the role of detection limits and resulting nondetects, which
are of practical importance for the application of the total
reflection X-ray fluorescence analysis in trace element stud-
ies. One of the routine analyses performed in our laboratory
is the determination of element concentration in the serum
of chemotherapy or/and radiotherapy patients in Holycross
Cancer Center (Kielce, Poland). The photon radiotherapy
and chemotherapy are the most often applied methods in the
treatment of cancer diseases. Knowledge on the biology of
normal cells and cancer cells allowing the understanding on
the growing processes of the cancer tissue, together with the
knowledge on the interaction of gamma rays with the mat-
ter, gives the possibility of effective fight with cancer. The
reaction which occurs between the gamma rays and human
body and the influence of the chemotherapy on the organ-
ism leads to metabolic changes. One of the effects of the
discussed treatment methods is modification of main and
trace element concentration in different human tissues and
fluids [6, 7]. It has been found that copper concentration in
serum correlates with tumour incidence and burden, malig-
nant progression and recurrence in many different human
cancers [6–8]. For example, an increased level of copper in
the serum is observed for Hodgkin’s disease, and changes
in copper concentration in human serum are observed dur-
ing the chemotherapy process [7, 8]. The observation of
these modification before, during and after radiotherapy and
chemotherapy, can give information about the effectiveness
of the treatment process. The main aim of this presented
study is a wide and systematic analysis of element con-
centration in different human biological materials (serum,
hair, tissue) of radiotherapy and chemotherapy patients, and
application of obtained results in formulating a general
observation which can be used as a tool for monitoring the
treatment process. The study is performed with the approval
of the Bioethics Committee at Holycross Medical Chamber.
Under the proposed research programme, which is the first
stage of the described long-term study, we have started mon-
itoring the copper concentration in human serum of patients
with malignant tumour during chemotherapy. Copper is an
essential trace element with many physiological functions.
It affects the activity of many enzymes, which are essential
for cellular respiration, defence against free radicals, for-
mation of connective tissue and for iron metabolism [9].
In the context of the cancer diseases, the role of cooper in
tumour angiogenesis has been demonstrated, and the reduc-
tion of the copper level in cancer patients has become one
of the approaches in antiangiogenic treatment [9]. Taking
into account that a common problem in biomedical studies
is the comparison of trace element contents in two, usu-
ally differently selected, populations or control group, the
performed analysis was also supplemented by systematic
studies on copper level in the group of healthy persons. In
the case of the latter group, the main aim was determina-
tion of the reference level of copper concentration in human
serum, understood as a mean value or a quantile range for
different confidence levels. These values can be next used
in cancer research programme. In this presented paper, the
experimental setup of the TXRF method and the calibra-
tion procedure will be briefly discussed. Next, the groups
of the samples and the sample preparation procedure will
be described. The results of copper concentration analy-
sis in serum for the control group and chemotherapy group
will be presented together with two-group comparison. In
performed systematic investigations of copper concentra-
tion in human serum samples by using the total reflection
X-ray fluorescence method, taking into account a large
number of analysed samples, it will be possible to describe
the nature of these distributions, and also several impor-
tant methodological aspects related to copper concentration
distributions can be addressed.
Material and Methods
Method of Analysis
In the present study, the TXRF method was used to deter-
mine the concentration of copper in human serum. This
method is a modification of the X-ray fluorescence method
(XRF) [10, 11] with special experimental geometry. In clas-
sical XRF technique, X-ray is directed on the analysed
samples at the angle close to 45◦ and a detector regis-
tering the characteristic X-ray emitted from the sample is
mounted in the geometry of 90◦ with respect to the primary
beam of X-ray photons (mainly for reducing the detection
of X-ray scattering). The main idea of the experimental
geometry modification in TXRF technique is that incom-
ing X-ray is directed on a flat carrier disc, usually polished
quartz (or silicon wafer), on which the analysed sample is
deposited, at a small angle, being below the critical angle
of the X-ray total external reflection. The value of criti-
cal angle depends on the X-ray energy and on the carrier
disc material, and for quartz and energy 17.44 keV (Mo-Kα
line) is equal to 0.1◦. Next, the incoming X-rays are totally
reflected from the carrier disc, and as the result, the pri-
mary beam penetrates the sample only on the depth of a few
nanometers. The scattering processes are reduced, and the
background in the analysed X-ray spectrum is much lower.
Additionally, the characteristic X-ray detector is mounted
close (∼3–4 mm) to the analysed sample (still in geom-
etry 90◦). Consequently, the detection limit is improved
about factor 103. In the presented study, the characteristic
X-rays were excited in the samples by a collimated beam of
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photons from 2-kW Siemens Mo-anode X-ray tube operated
at 40 kV with an electron current of 40 mA. The total reflec-
tion X-ray measurements were performed using the TXRF
attachment module [2] developed at Atominstitut, Vienna.
The primary X-rays from the tube were first collimated to
a size of 50 μm × 10 mm. Next, the X-rays were directed
onto a reflector which, as a results of the X-ray’s total exter-
nal reflection phenomenon, cuts off the high-energy X-rays
just above the Mo-Kα line. The reflected X-ray beam was
formed by the collimator additionally mounted in our exper-
imental setup for improving the detection limit of the TXRF
method by a reduction of the X-ray’s scattering [12]. The
primary beam, formed in such way, was next directed onto
the studied sample. The fluorescence characteristic of X-
rays from the samples was detected by a Si(Li) detector
having an energy resolution of 170 eV at 6.4 keV. The cal-
ibration of the instrument was performed using both ICP
Multi-Elemental Merck Standard Solution IV (Ag, Al, B,
Ba, Bi, Ca, Cd, Co, Cr, cu, Fe, Ga, In, K, Li, Mg, Mn,
Na, Ni, Pb, Sr, Tl, Zn) and mono-element (Ag, As, Ca, Cd,
Cl, K, P, Rb, S, Sc, Se, Ti, W) Merck standard calibrat-
ing solutions. The initial concentration of each solution was
1,000 mg/L. The calibration procedure and, consequently,
the routine measurements were performed with application
of yttrium as an internal standard. The calibration measure-
ments were next applied in the calculation of the calibration
curve, as presented in Fig. 1 for the elements analysed by
the identification of the characteristic K-shell X-ray lines
emitted from the sample. The calibration curve allows for
the quantitative analysis of the analysed samples. For the
XRF/TXRF methods, the detection limit for the determi-
nation of the concentration of a given element depends on
the intensity of characteristic X-ray line of interest as well
as the level of background intensity and measurement time.
More precisely, a concentration of trace element can be
determined by the X-ray fluorescence only when the total
number of counts in the corresponding X-ray line, Npeak,
exceeds in a statistically significant way the corresponding
background level, Nbkg, in the measured X-ray spectrum.
Usually, one assumes that the concentration detection limit
CDL is defined by the “three standard deviation rule,” which,
for the counting process, reads as follows: Npeak ≥ 3
√
Nbkg
[2]. Both the peak and background intensities, Npeak and
Nbkg, respectively, can be routinely obtained by using the
available X-ray spectra fitting software, and consequently,
the values of measured concentrations C and detection lim-
its CDL can be calculated from the calibration sensitivity
curve of the method. The detection limit for the different
elements in a human serum sample for the 1-h measurement
is presented in Fig. 2. For copper (atomic number Z = 29),
the detection limit of the TXRF technique for our experi-
mental setup is on the level of 0.07 mg/L, which is much
lower than the physiological values observed for copper
Fig. 1 The calibration curve of TXRF method for the elements anal-
ysed by the identification of the characteristic K-shell X-ray emitted
from the sample. The calibration curve allows for the quantitative
analysis of the analysed samples
concentration in human serum. Additionally, our elemental
analysis characterizes the accuracy on the level of 15 % and
repeatability of about 5 %.
Human Serum Samples
The total reflection X-ray fluorescence method in the
presented research programme was applied for the determi-
nation of the copper concentration of two groups of human
serum samples. The first group of samples, called control
group (CG), consisted of the serum samples of 44 healthy
persons between 18 and 45 years of age who donated blood
voluntarily, being employees of Holycross Cancer Center
(HCC) in Kielce, Poland, undergoing periodic exami-
nation. The second group of the human serum samples,
Fig. 2 The dependence of the detection limit on the atomic number of
the analysed element obtained for use in the presented study on TXRF
method setup. The values of the level of detection limit were obtained
for human serum sample for the 1 h measurement time. For copper
(atomic number Z = 29), the detection limit of the TXRF technique is
on the level of 0.07 mg/L
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called further chemotherapy group (CHG), was the serum
of 142 patients with malignant tumour who were at the
beginning of chemotherapy process. The main aim of the
analysis was the determination of the copper concentration
in serum. This information is used by the doctors in diag-
nostic process. The samples of blood were taken early in
the morning from an elbow vein of each patient after 12 h
without food and put into sterile tubes (disposable vacuum
tubes BD Vacutainer) with blue stopper, for the analysis of
trace elements, made of transparent plastic—polyethylene
terephthalate (PET)—containing a clotting activator. The
time of transport of the blood to the laboratory is up to
4 h, and the temperature upon transport is 15–25 ◦C. Next,
the serum was prepared from each blood sample by cen-
trifugation. In the centrifugation process, the laboratory
centrifuge MPW-350e was used, with time of centrifugation
of 10 min and centrifugation rate of 1,669g (RCF). After
centrifugation, serum sample was transferred to an Eppen-
dorf and frozen with a temperature of about −20 ◦C. A
determined amount of serum (usually 0.5 mL, but in some
cases 0.2 mL due to insufficient amount of serum) of each
patient of the control group was separately mineralized in
a closed glass bottle with 1 mL of high-purity HNO3 acid,
0.5 mL of H2O2 (30 %), and 300 μL of water solution of
Y(NO3)2 as an internal standard. The serum samples of
the chemotherapy group were separately mineralized in a
closed glass bottle with 1 mL of high-purity HNO3 acid,
0.5 mL of H2O2 (30 %), and 100 μL of water solution
of Y(NO3)2 as an internal standard. Next, in both cases,
5 μL of solution was pipetted into quartz carrier disc, and
this drop was dried in infrared. The sample preparation
method was checked experimentally to determine possible
volatility losses, which could occur for some more volatile
elements. In fact, such losses were negligible for the cop-
per concentration, assuming the above-described sample
mineralization procedures. The prepared sample was next
analysed using TXRF methods. The X-ray spectra were
collected for a 1-h time for each sample. The measurement
time was 1 h mainly due to the observation that copper con-
centration can be on a quite low level (∼0.2 mg/L), while
the background observation in serum sample spectra is rel-
atively high. Additionally, in the future, it can be possible
to also analyse other elements from the measured spectra,
so the 1-h measurement time is a compromise between
the sample throughput and possibility of other element
detection. A typical example of the TXRF X-ray spectrum
measured for the human serum is presented in Fig. 3. In the
X-ray spectra, the peak of copper was identified. Addition-
ally, K- and L-lines of the other elements (for example, K,
Ca, Ti, Cr, Fe, Zn, Br, Rb, Pb) were also observed. In the
first step of the discussed research programme, the level of
copper in the human serum samples was taken into account,
and the concentration of this element was calculated using
Fig. 3 A typical TXRF spectrum of a human serum sample excited by
the primary X-rays emitted from a Mo-anode X-ray tube. The yttrium
Kα X-ray line is from the internal standard added for the calibration
purpose. The copper atoms are identified in the measured spectrum by
their characteristic Kα X-rays (marked in bold). In the measured X-ray
spectrum, also the characteristic X-rays of other elements are observed
calibration curve. The experimental methodological uncer-
tainties of measured concentrations were usually within 15 %.
Results and Discussion
The results were carefully analysed to investigate the con-
centration distribution of copper in the studied two groups
of human serum samples. The parameters of concentra-
tion distributions, i.e. mean value, standard deviation and
median, were calculated both for control and chemotherapy
groups.The calculated values are summarized in Table 1.
In the table, also the numbers of studied samples and
range of the measured copper concentration are presented.
It was observed that the group of chemotherapy patients
is characterized by higher values of all parameters com-
pared to the control group. Moreover, the range of the
observed copper concentrations, defined as the range from
the lowest to the highest measured concentration, is much
wider in the chemotherapy group. Also extremely high
Table 1 Mean values, medians and standard deviations of copper
concentrations in the human serum samples for two studied groups,
namely for control and chemotherapy groups
Group Parameters (mg/L)
(Number of samples)
Mean Median Standard Range
value deviation (min ÷ max)
Control (44) 1.08 0.97 0.551 0.213 ÷ 2.50
Chemotherapy (142) 1.78 1.68 0.909 0.397 ÷ 6.64
Also the numbers of studied samples and the range of the measured
copper concentration are presented
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concentrations, sometimes called “outliers,” are observed
in this group. The variation coefficient for both groups is
almost on the same level. The mean value of the copper
concentration (1.08 mg/L) in human serum observed for the
control group agrees with the results of other authors [6].
Compared with the mean value, a relatively high value of
the standard deviation of the copper concentration distribu-
tion is, for this group, a result of physiological reason and
biological variation in the individual person, as influenced
by many different factors (sex, age, diet, environmental pol-
lution, etc). Analysing the chemotherapy group, separately
for males (77 samples) and females (65 samples), very sim-
ilar values of copper concentration were obtained for male
and female groups, namely mean 1.777 and 1.775 mg/L;
median 1.722 and 1.652 mg/L; and standard deviation 0.951
and 0.864 mg/L, respectively. Taking into account that these
results and the fact that no statistical significant differ-
ences were observed between means, the male and female
groups were not distinguished and were analysed as one
group. The distributions of copper concentration in anal-
ysed human serum samples were graphically presented in
Fig. 4. As it is shown in the figure, the histograms were
found to be strongly asymmetric and long-tailed, as it
was similarly observed for other medical samples in our
earlier studies [1]. It is worth to mention here that such
asymmetric concentration distributions of trace element in
medical samples are well described by the log-normal dis-
tribution or more general log-stable distribution [13]. The
log-stable character of the measured concentration distribu-
tions of trace elements was evidenced by demonstrating that
the logarithmically transformed concentrations (x ′ = lnx)
are described by the α-stable distribution Sα(μ,σ ,β) [13],
where α is the index of stability; μ and σ are the loca-
tion and scale parameters, respectively; and β is asymmetry
Fig. 4 The histograms of the copper concentration distributions mea-
sured by TXRF method in two groups of human serum samples,
namely in control and chemotherapy patients groups. The estimated
mean values (x¯) and standard deviations (S) are shown in the figure
parameter. Taking into account that the α-stable distribu-
tion for α = 2 is the Gaussian (normal) distribution, the
theoretical model yields in this case the log-normal distri-
bution of concentrations. For lower values 0 < α < 2,
the concentrations have the log-stable distributions having
power-like tails, in contrast to the log-normal distribution
characterized by the exponential tails. In fact, the “outliers,”
which are observed in the measured distributions, can in fact
manifest the log-stable nature of the studied concentration
distributions. The results of the logarithmic transformation
of the measured concentration distributions of copper in
the control and chemotherapy groups are shown in Fig. 5.
The α-stable distributions Sα(μ,σ ,β) were fitted to the log-
arithmically transformed (x ′ = lnx) concentrations using
the STABLE code developed by Nolan [14, 15]. In this fit-
ting, only the symmetric stable distributions Sα(μ,σ ,0) were
considered, which were a sufficient approximation tested
separately. Figure 5 shows the fitted values of the stabil-
ity index α for the copper concentration distribution in the
control (CG) and chemotherapy (CHG) groups. The concen-
trations of copper in the control group were found to be well
described by the log-normal model (α = 2.0), while the cop-
per concentrations in the chemotherapy group could be only
well reproduced by the log-stable model with stability index
α = 1.83. This observation was supported by the Anderson-
Darling A2 test [16], known as very sensitive for the tails
of distribution, used as a “goodness-of-fit” test. The A2 test
was applied both for testing the normality of the copper dis-
tribution in the control group and for testing the normality
Fig. 5 The histograms of the logarithmically transformed (x′ = lnx)
copper concentration distributions measured by the TXRF method in
two groups of human serum samples: in control and chemotherapy
patients groups. The histograms are presented with fitted normal distri-
bution (control group) and symmetric α-stable distribution Sα (μ,σ ,0)
(chemotherapy group). The case of the normal distribution corresponds
to the stability index α = 2.0. The Anderson-Darling test supported, at
the confidence level of 95 %, a normality of the transformed concen-
tration distribution for the control group and stability (α = 1.83) for
the chemotherapy group
Analysis of Copper Concentration in Human Serum 27
and stability of the copper distribution in the chemotherapy
group. Finally, the Anderson-Darling test supported, at 95 %
confidence level, that the measured concentration distribu-
tion of copper is log-normal (α = 2.0) for the control group
while log-stable (α = 1.83) for the chemotherapy group.
The main interpretation of the log-stability of the copper
serum concentration distribution in the chemotherapy group
is a fact that in the log-stable distributions, extremely high or
extremely low values of concentration can be observed with
higher probability, compared with log-normal distributions.
It is known that the copper level in the serum of tumour
patients is a result of many unexpected and complex factors
and processes [18]. Copper stimulates the proliferation and
migration of endothelial cells and is required for the secre-
tion of several angiogenic factors by tumour cells. Serum
copper levels are upregulated in many human tumours and
correlate with tumour burden and prognosis. Tumours may
exploit the role of copper by upregulating the expression
of copper-carrying proteins and pathways [18]. These pro-
cesses can result in extremely high values of copper serum
concentration, which confirms the presence of the log-stable
nature of the concentration distribution. It is worth empha-
sizing that copper chelators reduce tumour growth and
microvascular density, and synergy between copper chela-
tion and other treatment modalities such as chemotherapy
and radiotherapy is observed [18]. In sum, on the one hand,
the information about the kind of copper concentration dis-
tribution can model a process of copper accumulation in the
serum, but on the other hand, this information is a fact of
practical importance for further statistical data analysis, for
example, for a two-group comparison.
Fig. 6 Comparison of cumulative distribution functions obtained
(with ±σ confidence band) for copper concentrations of the control
and chemotherapy groups, respectively. The figure shows the calcu-
lated median (xmed) of the concentrations. The cumulative distribution
functions were compared by using the nonparametric Kolmogorov-
Smirnov test, which, on the confidence level of 95 %, confirms the
statistical difference between copper concentration in human serum for
the control and chemotherapy groups
Comparative Analysis
In order to make final conclusions concerning on a possi-
ble difference between the level of copper concentration in
two populations of samples, the control and chemotherapy
groups have to be compared systematically. First of all, as
it is shown in Fig. 6, the cumulative distribution functions
(cdf) of copper concentration for both groups were calcu-
lated. Using the Greenwood formula [17] for the variance,
the confidence bands of the empirical cumulative distribu-
tion function can be calculated for an assumed confidence
level. In Fig. 6, the graphs of the empirical cumulative dis-
tribution functions are plotted together with curves of the
confidence bands for the confidence level corresponding to
the one standard deviation (±σ ). The empirical cumulative
distribution functions were statistically compared using the
Kolmogorov-Smirnov D test [17], with the null hypothe-
sis that the data in both populations are drawn from the
same distribution. The Kolmogorov-Smirnov test does not
require any particular assumption concerning on a form of
the distribution. The calculated value of the test statistic
(D = 2.23) for analysed group comparison exceeds the
critical value (Dcrit = 1.35). The final result of the test
is a statistically significant difference between the level of
copper concentration in the control group compared with
the chemotherapy group, at the confidence level of 95 %.
Knowledge on the empirical cumulative distribution func-
tion Fˆ (x) allows one to estimate the quantile xˆp of p order
(for example, median xmed ≡ xˆ0.5) of the copper concen-
tration distribution by solving the equation Fˆ (xˆp) = p.
The xˆp parameter is a value of the measured concentra-
tion for which p percent of measured concentration is less
than xˆp. In statistical analysis, usually the following quan-
tiles are discussed: xˆ0.05, xˆ0.1, xˆ0.25, xˆ0.75, xˆ0.9, and xˆ0.95.
Basing on these quantiles, the corresponding ranges of the
reference values can be defined: xˆ0.05 ÷ xˆ0.95 (5 % of the
lowest and 5 % of the highest measured concentrations
are rejected) and, respectively, the ranges xˆ0.1 ÷ xˆ0.9 and
xˆ0.25 ÷ xˆ0.75. The values of the discussed quantiles and
the reference ranges calculated in the presented studies
for copper concentrations measured in control group are
summarized in Table 2.
Table 2 The different ranges of the reference values of copper level
in human serum obtained using the following quantiles calculated for
the copper concentrations measured in the control group: xˆ0.05, xˆ0.1,
xˆ0.25, xˆ0.75, xˆ0.9, and xˆ0.95
Control group
Quantiles range (mg/L)
xˆ0.25 ÷ xˆ0.75 xˆ0.1 ÷ xˆ0.9 xˆ0.05 ÷ xˆ0.95
0.625 ÷ 1.491 0.464 ÷ 1.90 0.273 ÷ 1.94
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Conclusions
The main aim of the presented work was concentrated on
the determination of the copper concentration in the human
serum samples for two different population, namely for
the control group and for the chemotherapy patient group.
The copper concentrations were determined in the samples
by using the total reflection X-ray fluorescence method.
This presented paper describes the main applications of
this technique, the calibration procedure and the sample
preparation procedure applied in the discussed studies. Per-
formed measurements allowed the calculation of the copper
concentration distribution parameters (mean value, standard
deviation, median) for both analysed groups. The relatively
large numbers of analysed samples for both studied groups
give the possibility of presentation of the new methodol-
ogy of data analysis. The advantage of this approach is the
interpretation of the theoretical shape of the copper concen-
tration distribution. It was found that the copper distribution
in the control group is well described by the log-normal dis-
tribution, while in the chemotherapy group, the log-stable
distribution was fitted. These observation were confirmed
by the Anderson-Darling test. The log-stable characteris-
tic of copper concentration distribution in serum of the
chemotherapy group provides the appearance of extremely
high copper concentration. The second new aspect was a sta-
tistical comparison of the copper concentration distributions
for the studied group by using the Kolmogorov-Smirnov test
with the conclusion that distributions are statistically dif-
ferent. The mean value and median of the copper level in
chemotherapy patient group is much higher compared to
that of the control group (1.08, 0.97 and 1.78 mg/L, and
1.68 mg/L, respectively). One of the main results of the
performed studies was also the determination of copper con-
centration reference ranges in human serum based on the
results obtained for the control group. Values of the mean,
median and other quantiles determined in this case will be
applied in our research programme, for example, in daily
routine analysis of copper level in serum of patients with
Hodgkin’s disease. The presented studies, which were con-
centrated on copper level which is of importance from the
point of view of our research programme, we are going
to extend by including the analysis of the concentration of
other elements determined in human serum for chemother-
apy and control groups as well as by discussion of the ratios
of specific pairs of elements (Cu/Zn, Fe/Mn, Se/Cu). The
number of the human samples in the control group will be
also systematically increased in the near future. Addition-
ally, in the studies on trace element concentration in serum
of the chemotherapy patients, also the kind of the cancer
and the stage of chemotherapy process will be taken into
account. Parallel to the comparison of the levels of element
concentration, also a discussion of the biochemical serum
parameters will be performed in our next study.
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